M42 and Arcera have formed a partnership aimed at accelerating the growth of medicine and biotechnology sectors in Abu Dhabi. This collaboration seeks to enhance the development and application of advanced medical solutions within the emirate. The initiative underscores Abu Dhabi's commitment to becoming a hub for healthcare innovation. Why it matters: This partnership signifies a strategic move to advance healthcare innovation and economic diversification within the UAE, leveraging potential AI applications in biotech to drive regional development.
The Abu Dhabi Department of Health (DoH) has partnered with MBZUAI and Core42 to launch the Global AI Healthcare Academy. The academy will provide AI training to healthcare workers in Abu Dhabi, aiming to improve diagnostics, operational efficiency, and patient care. The initiative includes mass training sessions for up to 100 attendees and customized courses in areas like AI for radiology and cardiology. Why it matters: This partnership signals a strategic push to integrate AI into Abu Dhabi's healthcare system, potentially establishing the emirate as a leader in technology-driven healthcare.
MBZUAI and Quris-AI have partnered to launch a Bio-AI center in Abu Dhabi during Abu Dhabi Sustainability Week. The center will focus on developing personalized medications tailored to the MENA region's diverse populations, leveraging Quris-AI's 'patient-on-a-chip' technology and MBZUAI's AI expertise. Quris-AI is establishing a UAE subsidiary, Quris-UAE, in Abu Dhabi as part of this collaboration. Why it matters: This initiative positions Abu Dhabi as a hub for Bio-AI research and personalized medicine, potentially accelerating drug development and reducing clinical trial failures in the region.